Elevation of Alanine Transaminase and Markers of Liver Fibrosis After a Mixed Meal Challenge in Individuals with Type 2 Diabetes

[1]  D. Torres,et al.  A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial , 2009, Journal of clinical gastroenterology.

[2]  R. Kreis,et al.  High protein intake reduces intrahepatocellular lipid deposition in humans. , 2009, The American journal of clinical nutrition.

[3]  J. George,et al.  Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss , 2009, Hepatology.

[4]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[5]  D. Reeds,et al.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. , 2009, Gastroenterology.

[6]  M. Knuiman,et al.  NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study , 2009, The American Journal of Gastroenterology.

[7]  J. Everhart,et al.  Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. , 2009, Gastroenterology.

[8]  A. West,et al.  Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay , 2008, Hepatology.

[9]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[10]  P. Lundberg,et al.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects , 2008, Gut.

[11]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[12]  Christopher J. Parsons,et al.  Molecular mechanisms of hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.

[13]  E. Georgescu,et al.  Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[14]  I. Guha,et al.  Future use of the Glasgow alcoholic hepatitis score. , 2006, Gut.

[15]  I. Guha,et al.  Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease , 2006, Gut.

[16]  Reza Malekzadeh,et al.  Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B , 2005, BMC gastroenterology.

[17]  K. Şahin,et al.  Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. , 2005, Hepato-gastroenterology.

[18]  D. Lawlor,et al.  The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. , 2005, American journal of epidemiology.

[19]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[20]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[21]  L. Rallidis,et al.  Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study. , 2004, Atherosclerosis.

[22]  I. Suh,et al.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.

[23]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[24]  A. Häkkinen,et al.  Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. , 2003, Diabetes.

[25]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[26]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[27]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[28]  J. Peters,et al.  Fat and carbohydrate overfeeding in humans: different effects on energy storage. , 1995, The American journal of clinical nutrition.

[29]  W. Siri.  Body composition from fluid spaces and density: analysis of methods. 1961. , 1993, Nutrition.

[30]  K. Majamaa,et al.  Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. , 1988, Clinical and experimental rheumatology.

[31]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[32]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[33]  D. Reeds,et al.  Kirk E, Reeds DN, Finck BN et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009; 136:1552―1560 , 2009 .

[34]  W. Siri,et al.  Body composition from fruid spaces and density : analysis of method. Techniques for measuring body composition , 1961 .

[35]  Josef Brozek,et al.  Techniques for measuring body composition , 1961 .